| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |